• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性血液病患者的尿石症。

Urolithiasis in patients suffering from malignant hematologic diseases.

机构信息

Department of Urology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Yonsei Med J. 2010 Mar;51(2):244-7. doi: 10.3349/ymj.2010.51.2.244. Epub 2010 Feb 12.

DOI:10.3349/ymj.2010.51.2.244
PMID:20191017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2824871/
Abstract

PURPOSE

We performed this study in order to evaluate the incidence and characteristics of urolithiasis in patients with malignant hematologic diseases.

MATERIALS AND METHODS

Nine hundred one patients who underwent medical treatment for malignant hematologic disease and 40,543 patients who visited the emergency room and without malignant hematologic diseases were included in our study. The patients with malignant hematologic diseases were divided into two groups depending on their primary treatment. Group I included patients with acute and chronic leukemia (AML, ALL, CML, CLL) for which chemotherapy and steroid therapy was necessary, and group II included patients with anaplastic anemia and myelodysplastic syndrome and who had undergone repeated transfusion for treatment. Comparisons were made between the two groups in respect to the incidence of urolithiasis and the stones' radiopacity.

RESULTS

Twenty nine patients (3.2%) of the 901 malignant hematologic patients were diagnosed with urolithiasis, compared to 575 patients (1.4%) of 40,543 emergency room patients. There was a significant increase of the incidence of urolithiasis in the malignant hematologic group. Compared to the general patients, the patients with malignant hematologic diseases had a higher rate of radiolucent stones (46.6% versus 16.3%, respectively), and the difference was significant.

CONCLUSION

The incidence of urolithiasis for malignant hematologic patients was significantly higher than that for the control group.

摘要

目的

我们进行这项研究是为了评估恶性血液病患者中尿路结石的发生率和特征。

材料和方法

本研究纳入了 901 名接受恶性血液病治疗的患者和 40543 名因恶性血液病以外的疾病就诊急诊室的患者。根据主要治疗方法将恶性血液病患者分为两组。组 I 包括接受化疗和类固醇治疗的急性和慢性白血病(AML、ALL、CML、CLL)患者,组 II 包括接受反复输血治疗的再生障碍性贫血和骨髓增生异常综合征患者。比较两组尿路结石的发生率和结石的放射密度。

结果

901 例恶性血液病患者中,29 例(3.2%)诊断为尿路结石,而 40543 例急诊室患者中,575 例(1.4%)诊断为尿路结石。恶性血液病组尿路结石的发生率明显增加。与普通患者相比,恶性血液病患者的透光性结石发生率更高(分别为 46.6%和 16.3%),差异有统计学意义。

结论

恶性血液病患者尿路结石的发生率明显高于对照组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/2824871/23c5c939ec38/ymj-51-244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/2824871/bac95605d802/ymj-51-244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/2824871/23c5c939ec38/ymj-51-244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/2824871/bac95605d802/ymj-51-244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8534/2824871/23c5c939ec38/ymj-51-244-g002.jpg

相似文献

1
Urolithiasis in patients suffering from malignant hematologic diseases.恶性血液病患者的尿石症。
Yonsei Med J. 2010 Mar;51(2):244-7. doi: 10.3349/ymj.2010.51.2.244. Epub 2010 Feb 12.
2
Systemic mastocytosis in the elderly.老年人系统性肥大细胞增生症。
Am J Hematol. 2013 May;88(5):406-8. doi: 10.1002/ajh.23426. Epub 2013 Mar 27.
3
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study.范可尼贫血的血液学异常:一项国际范可尼贫血登记研究
Blood. 1994 Sep 1;84(5):1650-5.
4
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.皮下注射促红细胞生成素治疗血液系统疾病中的难治性贫血。一项I/II期临床试验的结果。
Blood. 1992 Jan 1;79(1):29-37.
5
Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers.两所学术中心尿路结石急性和短期治疗中的辐射暴露情况。
J Urol. 2009 Feb;181(2):668-72; discussion 673. doi: 10.1016/j.juro.2008.10.012. Epub 2008 Dec 18.
6
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.惰性淋巴瘤患者接受清髓性放化疗及自体干细胞移植后继发性血液系统恶性肿瘤的中度增加:德国低度淋巴瘤研究组前瞻性随机试验的结果
J Clin Oncol. 2004 Dec 15;22(24):4926-33. doi: 10.1200/JCO.2004.06.016.
7
Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.血液系统疾病男性患者Y染色体缺失的分子遗传学证据。
Chin Med J (Engl). 2007 Nov 20;120(22):2002-5.
8
Incidence and Risk Factors for Urolithiasis in Patients with Crohn's Disease.克罗恩病患者尿路结石的发病率及危险因素
Urol Int. 2015;95(3):314-9. doi: 10.1159/000375536. Epub 2015 Apr 17.
9
Intracranial Hemorrhage in Patients with Hematologic Disorders: Prevalence and Predictive Factors.血液系统疾病患者的颅内出血:患病率及预测因素
J Med Assoc Thai. 2016 Jan;99(1):15-24.
10
Association between chronic pancreatitis and urolithiasis: A population-based cohort study.慢性胰腺炎与尿路结石的相关性:基于人群的队列研究。
PLoS One. 2018 Mar 9;13(3):e0194019. doi: 10.1371/journal.pone.0194019. eCollection 2018.

引用本文的文献

1
Complications of lymphoma in the abdomen and pelvis: clinical and imaging review.腹部和骨盆淋巴瘤的并发症:临床和影像学综述。
Abdom Radiol (NY). 2022 Aug;47(8):2937-2955. doi: 10.1007/s00261-022-03567-5. Epub 2022 Jun 12.
2
A Rare Case of Spontaneous Tumor Lysis Syndrome in Idiopathic Primary Myelofibrosis.原发性骨髓纤维化中自发性肿瘤溶解综合征的罕见病例
Am J Case Rep. 2019 Feb 3;20:146-150. doi: 10.12659/AJCR.912682.
3
Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature.

本文引用的文献

1
The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.类固醇对髓系白血病细胞的作用:短疗程大剂量甲泼尼龙治疗在诱导分化、凋亡及刺激骨髓生成方面的潜力。
Leuk Res. 2006 Jan;30(1):60-8. doi: 10.1016/j.leukres.2005.05.015. Epub 2005 Jun 24.
2
[Acute tumor lysis syndrome: update on therapy].[急性肿瘤溶解综合征:治疗进展]
Rev Med Interne. 2005 Jan;26(1):27-32. doi: 10.1016/j.revmed.2004.06.014.
3
Urolithiasis in pediatric patients with acute lymphoblastic leukemia.
梗阻性尿路病作为原发性骨髓纤维化的首发表现:病例报告及文献复习
Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):117-20. doi: 10.1007/s12288-016-0679-6. Epub 2016 May 7.
急性淋巴细胞白血病患儿的尿石症
Leukemia. 2003 Mar;17(3):541-6. doi: 10.1038/sj.leu.2402852.
4
Acute myeloid leukemia complicated with staghorn calculus.急性髓系白血病合并鹿角形结石
Jpn J Clin Oncol. 2002 Sep;32(9):365-7. doi: 10.1093/jjco/hyf077.
5
Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence.临床综述151:甲状旁腺激素在糖皮质激素诱导的骨质疏松症发病机制中的作用:对证据的重新审视。
J Clin Endocrinol Metab. 2002 Sep;87(9):4033-41. doi: 10.1210/jc.2002-012101.
6
Comprehensive analysis of citrate effects during plateletpheresis in normal donors.正常献血者血小板单采过程中柠檬酸盐效应的综合分析。
Transfusion. 2001 Sep;41(9):1165-71. doi: 10.1046/j.1537-2995.2001.41091165.x.
7
Prevalence and risk factors of urinary stones in Koreans.韩国人尿路结石的患病率及危险因素。
J Korean Med Sci. 1998 Apr;13(2):138-46. doi: 10.3346/jkms.1998.13.2.138.
8
Current aspects of epidemiology and nutrition in urinary stone disease.尿石症的流行病学与营养现状
World J Urol. 1997;15(3):165-71. doi: 10.1007/BF02201853.
9
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones.一项关于膳食钙及其他营养素与有症状肾结石风险的前瞻性研究。
N Engl J Med. 1993 Mar 25;328(12):833-8. doi: 10.1056/NEJM199303253281203.
10
Urolithiasis in childhood acute leukemia and nonHodgkin's lymphoma.儿童急性白血病和非霍奇金淋巴瘤中的尿路结石病
J Urol. 1986 Nov;136(5):1052-4. doi: 10.1016/s0022-5347(17)45206-2.